Evidence map›Paper›PMID 31431058›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Coenzyme Q

Ji Hyun Yu, Sun Woo Lim, Kang Luo, Sheng Cui, Yi Quan, Yoo Jin Shin, Kyung Eun Lee, Hong Lim Kim, Eun Jeong Ko, Byung Ha Chung and 3 more

Registry-linked trialOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04972552 (Watermelon/UBIQuinone Study), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04972552 naactive not recruitingnot on this mapstarted 2021, after this paper: background citation

Watermelon/UBIQuinone Study (WUBI-Q Trial)

TypeinterventionalSponsorUniversity of California, San FranciscoRan2021 to 2026Enrolled70ConditionsKidney TransplantationArmscoenzyme Q10, Watermelon diet, Usual Diet, Placebo
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Lipid metabolism ofWorld journal of diabetes · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Ji Hyun YuDepartment of Internal Medicine and The Catholic University of Korea School of Medicine, Seoul, South Korea.
Sun Woo LimConvergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, South Korea.
Kang LuoConvergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, South Korea.
Sheng CuiConvergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, South Korea.
Yi QuanConvergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, South Korea.
Yoo Jin ShinConvergent Research Consortium for Immunologic Disease, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, South Korea.
Kyung Eun LeeAdvanced Analysis Center, Korea Institute of Science and Technology, Seoul, South Korea.
Hong Lim KimIntegrative Research Support Center, The Catholic University of Korea School of Medicine, Seoul, South Korea.
Eun Jeong KoDepartment of Internal Medicine and The Catholic University of Korea School of Medicine, Seoul, South Korea.
Byung Ha ChungDepartment of Internal Medicine and The Catholic University of Korea School of Medicine, Seoul, South Korea.
Ju Hwan KimAbtis, Suwon, South Korea.
Sang J ChungSchool of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
Chul Woo YangDepartment of Internal Medicine and The Catholic University of Korea School of Medicine, Seoul, South Korea.
Catholic University of Korea · KRThe Catholic University of Korea Seoul St. Mary's Hospital · KRKorea Institute of Science and Technology · KRSungkyunkwan University · KRSuwon Research Institute · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The major side effect of tacrolimus (Tac) is nephrotoxicity. We studied whether supplementation of coenzyme Q

Indexed as

ApoptosisCells, CulturedHumansKidneyKidney Tubules, ProximalMembrane Potential, MitochondrialMitochondriaReactive Oxygen SpeciesTacrolimusUbiquinonecoenzyme Q10Reactive Oxygen SpeciesTacrolimusUbiquinone3D reconstructionnephrotoxicityreactive oxygen species

Identifiers

PMID31431058
PMCPMC6902707
OpenAlexW2969453151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.